Cargando…

Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells

Nucleotide-binding oligomerization domain 1 (NOD1) receptor and Toll-like receptor 4 (TLR4) belong to the family of pattern recognition receptors. Interactions between these receptors profoundly shape the innate immune responses. We previously demonstrated that co-stimulation of peripheral blood mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guzelj, Samo, Jakopin, Žiga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354050/ https://www.ncbi.nlm.nih.gov/pubmed/35935855 http://dx.doi.org/10.3389/fphar.2022.920928

Ejemplares similares

Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy
por: Nabergoj, Sanja, et al.
Publicado: (2018)

Synthesis of Conformationally Constrained d-Glu-meso-DAP Analogs as Innate Immune Agonists
por: Guzelj, Samo, et al.
Publicado: (2020)

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
por: Guzelj, Samo, et al.
Publicado: (2022)

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022)

Biocomputational analysis of evolutionary relationship between toll-like receptor and nucleotide-binding oligomerization domain-like receptors genes
por: Bhardwaj, Rabia, et al.
Publicado: (2016)

Upregulation of Nucleotide-Binding Oligomerization Domain-, LRR- and Pyrin Domain-Containing Protein 3 in Motoneurons Following Peripheral Nerve Injury in Mice
por: Nógrádi, Bernát, et al.
Publicado: (2020)

Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain
por: Hassan, Mujtaba, et al.
Publicado: (2021)

Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders
por: WATANABE, Tomohiro, et al.
Publicado: (2017)

The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced Nucleotide Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3/Autophagy, and Maintaining Intestinal Barrier Are Profitable in Colitis
por: Liu, Jiuxi, et al.
Publicado: (2019)

Isolated Toll-like Receptor Transmembrane Domains Are Capable of Oligomerization
por: Godfroy, James I., et al.
Publicado: (2012)

H3 Relaxin Alleviates Migration, Apoptosis and Pyroptosis Through P2X7R-Mediated Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Activation in Retinopathy Induced by Hyperglycemia
por: Yang, Kelaier, et al.
Publicado: (2020)

Different toxic effects of YTX in tumor K-562 and lymphoblastoid cell lines
por: Fernández-Araujo, Andrea, et al.
Publicado: (2015)

Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins
por: Dixon, Charneal L., et al.
Publicado: (2023)

Toll-Like Receptor (TLR) and Nucleosome-binding Oligomerization Domain (NOD) gene polymorphisms and endometrial cancer risk
por: Ashton, Katie A, et al.
Publicado: (2010)

Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases
por: Shi, Congjian, et al.
Publicado: (2020)

Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review
por: Minaga, Kosuke, et al.
Publicado: (2018)

Expression of nucleotide-binding oligomerization domain 1 and 2 in oral lichen planus
por: Ahn, Mee-Young, et al.
Publicado: (2020)

Identification of WT161 as a Potent Agent for the Treatment of Colitis by Targeting the Nucleotide-Binding Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome
por: Long, Xiuyan, et al.
Publicado: (2022)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation
por: Zhou, Ying, et al.
Publicado: (2017)

Iron-Binding and Anti-Fenton Properties of Novel Amino Acid-Derived Cyclic Imide Dioximes
por: Mravljak, Janez, et al.
Publicado: (2019)

Innovation in Nucleotide-Binding Oligomerization-Like Receptor and Toll-Like Receptor Sensing Drives the Major Histocompatibility Complex-II Free Atlantic Cod Immune System
por: Jin, Xingkun, et al.
Publicado: (2020)

Analysis of nucleotide-binding oligomerization domain proteins in a murine model of pneumococcal meningitis
por: Liu, Xinjie, et al.
Publicado: (2014)

Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of Atherosclerosis
por: Kim, Ha-Jeong
Publicado: (2015)

Nucleotide-binding oligomerization domain 1 is dispensable for host immune responses against pulmonary infection of Acinetobacter baumannii in mice
por: Kang, Min-Jung, et al.
Publicado: (2018)

Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation
por: Navarro, Rocío, et al.
Publicado: (2016)

Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection
por: Egarnes, Benoit, et al.
Publicado: (2018)

Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
por: Vlacil, Ann-Kathrin, et al.
Publicado: (2020)

Nucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
por: Kitajima, Natsuko, et al.
Publicado: (2023)

Activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 6 by Porphyromonas gingivalis regulates programmed cell death in epithelium
por: Liu, Jianru, et al.
Publicado: (2023)

Engagement of Nucleotide-binding Oligomerization Domain-containing Protein 1 (NOD1) by Receptor-interacting Protein 2 (RIP2) Is Insufficient for Signal Transduction
por: Mayle, Sophie, et al.
Publicado: (2014)

Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages
por: Moreno, L, et al.
Publicado: (2010)

Vitamin D ameliorates insulin resistance-induced osteopenia by inactivating the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome
por: Wu, Min, et al.
Publicado: (2023)

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
por: Cen, Xiaohong, et al.
Publicado: (2018)

Toll-Like Receptor 4 Signaling and Drug Addiction
por: Wu, Ruyan, et al.
Publicado: (2020)

MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling
por: Moncrieffe, Martin C., et al.
Publicado: (2020)

Nucleotide-Binding Oligomerization Domain-1 and -2 Play No Role in Controlling Brucella abortus Infection in Mice
por: Oliveira, Fernanda S., et al.
Publicado: (2012)

Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia
por: Hommes, Tijmen J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2bs4g5p8r1aeeai6fmisqet25q